Radiation Therapy Services Holdings, Inc. (RTSX) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010

21St Century Oncology Holdings, Inc.

CIK: 1503518 Ticker: RTSX

Exhibit 99.1










Kerrin Gillespie

Chief Financial Officer

Radiation Therapy Services, Inc.



Amy Glynn / Nick Laudico

The Ruth Group

646-536-7023 / 7030


Radiation Therapy Services Holdings, Inc. Reports Fourth Quarter

and Fiscal Year 2010 Financial Results


2010 Highlights:

·                  Acquisitions of a Myrtle Beach, South Carolina-based radiation therapy facility and four physician practices, expanding into new market

·                  Issued $310.0 million of Senior Subordinated Notes in April 2010; completed exchange offer for Senior Subordinated Notes in January 2011

·                  Completed advanced technology upgrades in six key markets

·                  Selected by key academic medical centers to serve as Developer and Managing Partner of first Proton Beam Radiation Therapy Center in New York

·                  2011 Physician Fee Schedule results in stable to slightly favorable reimbursement environment

·                  Strengthened management team with appointments of new CFO and COO


FORT MYERS, FL, February 28, 2011 —

Radiation Therapy Services Holdings, Inc. (“Radiation Therapy Services”), a leading operator of radiation therapy centers, today announced financial results for the fourth quarter and fiscal year ended December 31, 2010.


For the fourth quarter of 2010, total revenues were $137.5 million and the net loss was $102.3 million.  For fiscal year 2010, total revenues were $544.0 million and the net loss was $113.8 million. The quarterly and annual net losses were due primarily to goodwill impairment charges in certain financially distressed markets.


“We finished 2010 with many accomplishments despite continued challenging economic conditions,” said Dr. Daniel Dosoretz, President and Chief Executive Officer.  “As a



The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Friday, March 4, 2011 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 21St Century Oncology Holdings, Inc..


Assess how 21St Century Oncology Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

21St Century Oncology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors